CLBIO — Corline Biomedical AB Share News
0.000.00%
- SEK371.09m
- SEK338.10m
- SEK7.65m
Brief: Corline Q4 Net Sales Rise To SEK 8.2 Million
Brief: Corline Biomedical Q2 Result For Period Turns To Profit Of SEK 0.9 Mln
Brief: Corline Biomedical Signs Supplement To Existing License And Delivery Agreement With Kardium
Brief: European Patent Office To Approve Corline Biomedical's Renaparin Patents
Brief: Corline Biomedical Signs Agreement For Phase 2 Study In Kidney Transplantation
Brief: Corline Biomedical Q3 Loss After Financial Items Narrows To SEK 2.1 Mln
Brief: Corline Biomedical Signs Agreement With Imperative Care
Brief: Corline Biomedical Q2 Pretax Loss Narrows To SEK 2.2 Mln
Brief: Corline Biomedical Enters Term Sheet Regarding Additional Medical Applications In USA
Brief: Corline Q1 Pretax Loss Narrows To SEK 1.4 Million
Brief: Corline Biomedical Completes Directed Issue Of About SEK 35.5 Million
Brief: Corline Biomedical Q4 Pretax Loss Narrows To SEK 0.1 Mln
Brief: Corline Biomedical Extends Distribution Agreement In U.S.
Brief: Corline Biomedical Updates On Licence And Delivery Deal With Canadian Kardium
Brief: Corline Biomedical's Rights Issue Oversubscribed By 352%
Brief: Corline Biomedical Decides On Fully Secured Rights Issue Of SEK 15 Million
Brief: Corline Biomedical Q3 Pre-Tax Loss Widens To SEK 2.2 Mln
Brief: Corline Biomedical Q3 Pre-Tax Loss Widens To SEK 2.2 Million
Brief: Corline Biomedical AB - Enters Agreement With American Company